Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease

  • Authors:
    • Qing Ye
    • Ting-Feng Wang
    • Yuan-Fei Peng
    • Jing Xie
    • Bo Feng
    • Ming-Yuan Qiu
    • Liang-Hui Li
    • Ai-Guo Lu
    • Bing-Ya Liu
    • Min-Hua Zheng
  • View Affiliations

  • Published online on: February 1, 2010     https://doi.org/10.3892/or_00000652
  • Pages: 429-436
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The synucleins (α-, β- and γ-synuclein) are a small, soluble, highly conserved group of neuronal proteins that attracted considerable attention due to their involvement in both neurodegenerative diseases and cancer. In this study, we examined the synuclein exprsssion in colorectal cancer (CRC) tissues, tumor-matched non-neoplastic adjacent tissues (NNAT), and CRC cell lines, and then investigated clinical significance of synucleins. By using semi-quantitative RT-PCR, synuclein mRNA expression was detected in eight CRC cell lines. It was much higher in CRC samples than in NNAT samples (P<0.05). The results of western blotting showed that the levels of synucleins protein expression in CRC cells approximately corresponded to the levels of synuclein mRNA expression. Immunohistochemical staining revealed that γ-synuclein protein expression was up-regulated in CRC samples compared to NNAT samples (P=0.022), and was significantly correlated with clinical stage and lymph node involvement of CRC (P<0.05). Although, there was no significant difference in either α- or β-synuclein protein expression between tumor and normal samples (P>0.05), often more than one form of synuclein was expressed in a tumor sample. More ratios of later stage and lymph node-positive tumors expressed a least one type of synuclein protein, and more ratios showed positive for either α or γ-synuclein expression, as well as positive either for β or γ-synuclein in more ratios of lymph node-positive tumors. These results show that α-, β- and γ-synuclein are expressed in a high percentage of CRC. γ-synuclein protein is valuable for evaluation of progression of CRC, and it is more sensitive to predict advanced stage and lymph node invasion by detection of γ-synuclein protein combined with either α- or β-synuclein protein or both than by detection of γ-synuclein only.

Related Articles

Journal Cover

February 2010
Volume 23 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ye Q, Wang T, Peng Y, Xie J, Feng B, Qiu M, Li L, Lu A, Liu B, Zheng M, Zheng M, et al: Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Oncol Rep 23: 429-436, 2010.
APA
Ye, Q., Wang, T., Peng, Y., Xie, J., Feng, B., Qiu, M. ... Zheng, M. (2010). Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Oncology Reports, 23, 429-436. https://doi.org/10.3892/or_00000652
MLA
Ye, Q., Wang, T., Peng, Y., Xie, J., Feng, B., Qiu, M., Li, L., Lu, A., Liu, B., Zheng, M."Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease". Oncology Reports 23.2 (2010): 429-436.
Chicago
Ye, Q., Wang, T., Peng, Y., Xie, J., Feng, B., Qiu, M., Li, L., Lu, A., Liu, B., Zheng, M."Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease". Oncology Reports 23, no. 2 (2010): 429-436. https://doi.org/10.3892/or_00000652